Providing a diverse range of perspectives from bullish to bearish, 14 analysts have published ratings on Sage Therapeutics (NASDAQ:SAGE) in the last three months.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 3 | 10 | 0 | 1 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 2 | 6 | 0 | 0 |
| 2M Ago | 0 | 1 | 2 | 0 | 0 |
| 3M Ago | 0 | 0 | 1 | 0 | 1 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $16.64, with a high estimate of $25.00 and a low estimate of $8.00. This current average has decreased by 18.83% from the previous average price target of $20.50.
Deciphering Analyst Ratings: An In-Depth Analysis
The analysis of recent analyst actions sheds...
ログインすると全部閲覧できます。
ログイン